Technical Analysis for ADRO - Aduro Biotech, Inc.

Grade Last Price % Change Price Change
grade D 3.2 1.91% 0.06
ADRO closed up 1.91 percent on Friday, May 24, 2019, on 75 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Flat
See historical ADRO trend table...

Date Alert Name Type % Chg
Wide Bands Range Expansion 0.00%
Wide Bands Range Expansion 1.91%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -1.84%
Outside Day Range Expansion -1.84%
Wide Bands Range Expansion -1.84%
Wide Bands Range Expansion -0.62%
Wide Bands Range Expansion -1.23%
NR7 Range Contraction 2.24%
Wide Bands Range Expansion 2.24%
Down 3 Days in a Row Weakness 2.24%

Older signals for ADRO ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Aduro BioTech, Inc., a clinical-stage immuno-oncology company, focuses on the development of technology platforms designed to stimulate robust and durable immune responses against cancer. Its lead product candidate is CRS-207, which is in a Phase IIb clinical trial for the treatment of metastatic pancreatic cancer and unresectable malignant pleural mesothelioma. The company's cyclic dinucleotides product candidates are synthetic small molecule immune modulators that target and activate Stimulator of Interferon Genes receptor. Aduro BioTech, Inc. has collaboration agreement with Janssen Biotech, Inc. to develop drugs for the treatment of prostate and lung cancers. The company was formerly known as Oncologic, Inc. and changed its name to Aduro BioTech, Inc. in June 2008. Aduro BioTech, Inc. was founded in 2000 and is based in Berkeley, California.
Medicine Cancer Cancer Immunotherapy Technology Platforms Metastatic Pancreatic Cancer Johnson & Johnson Lung Cancers
Is ADRO a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 9.0
52 Week Low 2.34
Average Volume 385,182
200-Day Moving Average 4.2023
50-Day Moving Average 3.7022
20-Day Moving Average 3.5615
10-Day Moving Average 3.193
Average True Range 0.2688
ADX 18.08
+DI 16.7429
-DI 22.5613
Chandelier Exit (Long, 3 ATRs ) 3.7836
Chandelier Exit (Short, 3 ATRs ) 3.6264
Upper Bollinger Band 4.5078
Lower Bollinger Band 2.6152
Percent B (%b) 0.31
BandWidth 53.140531
MACD Line -0.1705
MACD Signal Line -0.1441
MACD Histogram -0.0264
Fundamentals Value
Market Cap 238.76 Million
Num Shares 74.6 Million
EPS -1.56
Price-to-Earnings (P/E) Ratio -2.05
Price-to-Sales 35.46
Price-to-Book 2.36
PEG Ratio 0.05
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 3.47
Resistance 3 (R3) 3.45 3.33 3.43
Resistance 2 (R2) 3.33 3.26 3.35 3.41
Resistance 1 (R1) 3.27 3.22 3.30 3.29 3.39
Pivot Point 3.15 3.15 3.17 3.17 3.15
Support 1 (S1) 3.09 3.08 3.12 3.11 3.01
Support 2 (S2) 2.97 3.04 2.99 2.99
Support 3 (S3) 2.91 2.97 2.98
Support 4 (S4) 2.93